Drugs / GX-051
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02079324 | Mar 2014 → Sep 2016 | head and neck cancer | Genexine, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GX-051 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02079324 ↗ |
| Route | Other | “intratumoral injection” NCT02079324 ↗ |